Publication | Open Access
Piperazine-substituted chalcones: a new class of MAO-B, AChE, and BACE-1 inhibitors for the treatment of neurological disorders
48
Citations
36
References
2021
Year
Medicinal ChemistryPiperazine-substituted ChalconesMedicineBace-1 InhibitorsPharmacological AgentNeuropharmacologyNew ClassNeuroprotectionNeurologyPharmacotherapyNeurosciencePharmacologyDrug Discovery
| Year | Citations | |
|---|---|---|
Page 1
Page 1